Back to Results
First PageMeta Content
Amines / Drug rehabilitation / Eli Lilly and Company / Ketones / Methadone / Pharmacokinetics / Fluorouracil / Chemistry / Pharmacology / Pharmaceutical sciences


FOR IMMEDIATE RELEASE Saladax Biomedical, Inc. Announces the Presentation of the CESAR Study Results for Pharmacokinetically-Guided Dosing of 5-Fluorouracil in Colorectal Cancer at 2015 ASCO Meeting Advantages of a Prac
Add to Reading List

Document Date: 2015-06-05 12:05:34

Open Document

File Size: 182,59 KB

Share Result on Facebook

City

Chicago / BETHLEHEM / /

Company

Saladax Biomedical Inc. / /

Continent

Europe / /

Country

Germany / China / United States / /

IndustryTerm

pharmaceutical products / value diagnostic services / /

MedicalCondition

Colorectal Cancer / /

Organization

Central European Society for Anticancer Research / American Society of Clinical Oncology / /

Position

leader in the development / /

Product

Fluorouracil / /

ProvinceOrState

Illinois / Pennsylvania / /

URL

www.saladax.com / /

SocialTag